These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3611775)

  • 1. Chemical renal medullectomy prevents frusemide-induced inhibition of sympathetic vasoconstriction in the in situ blood perfused rat mesentery.
    Gerkens JF; Armsworth SJ; Bhagwandeen SB; Smith AJ
    J Hypertens; 1987 Jun; 5(3):273-5. PubMed ID: 3611775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of frusemide on sympathetic vasoconstrictor responses: dependence on a renal hormone and the vascular endothelium.
    Gerkens JF
    Clin Exp Pharmacol Physiol; 1987 May; 14(5):371-7. PubMed ID: 3677482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frusemide inhibition of sympathetic vasoconstriction in the rat in situ blood perfused mesentery.
    Armsworth SJ; Gerkens JF; Smith AJ
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):495-503. PubMed ID: 3757313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-dependent inhibition of sympathetic vasoconstriction by frusemide administration to rats.
    Gerkens JF; Armsworth SJ; Dosen PJ; Smith AJ
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):449-55. PubMed ID: 3271618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sympathetic constriction of the ex vivo tail artery perfused with blood from rats given frusemide.
    Gerkens JF; Armsworth SJ; Smith AJ
    Clin Exp Hypertens A; 1987; 9(1):51-79. PubMed ID: 3107857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vasoconstriction by frusemide in the rat.
    Gerkens JF; Smith AJ
    Br J Pharmacol; 1984 Oct; 83(2):363-71. PubMed ID: 6487901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vasoconstriction by platelet activating factor in the in situ blood perfused rat mesentery.
    Gerkens JF
    Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):161-7. PubMed ID: 2721028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 17 beta-oestradiol on vascular responses in the in situ blood-perfused mesentery of Wistar-Kyoto rats.
    Chu ZM; Beilin LJ
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):430-2. PubMed ID: 9171950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
    Fernández MM; Morán A; Martín ML; San Román L
    Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.
    Du QH; Han L; Jiang JJ; Xu Y; Li WH; Li PT; Wang XY; Jia X
    World J Gastroenterol; 2014 Nov; 20(44):16674-82. PubMed ID: 25469036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vasoconstrictor mechanisms by dazoxiben in the rat mesenteric vasculature.
    Li DM; De Garis RM; Dusting GJ
    Eur J Pharmacol; 1985 Apr; 110(3):351-6. PubMed ID: 3924637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unclipping of two-kidney, one clip hypertensive rats produces endothelium-dependent inhibition of sympathetic vasoconstriction.
    Gerkens JF
    J Hypertens; 1989 Dec; 7(12):961-6. PubMed ID: 2628496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT
    García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Rodríguez-Barbero A; Martín ML; Morán A
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1224-1231. PubMed ID: 28771848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed.
    Pakdeechote P; Rummery NM; Ralevic V; Dunn WR
    Eur J Pharmacol; 2007 Jun; 563(1-3):180-6. PubMed ID: 17367778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the adrenal medulla in control of blood pressure and renal function during frusemide-induced volume depletion.
    Hasbak P; Petersen JS; Shalmi M; Lam HR; Christensen NJ; Christensen S
    J Hypertens; 1995 Feb; 13(2):235-42. PubMed ID: 7615954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity and dissimilarity of the vasoconstrictor effects of Bay K 8644 on coronary, femoral, mesenteric and renal circulations of dogs.
    Ishii K; Sato Y; Taira N
    Br J Pharmacol; 1986 Jun; 88(2):369-77. PubMed ID: 2425879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of frusemide on renal medullary and cortical blood flow in the anaesthetised rat.
    Dobrowolski L; B dzyńska B; Sadowski J
    Exp Physiol; 2000 Nov; 85(6):783-9. PubMed ID: 11187972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renal papillary-medullary lesion on the antihypertensive effect of furosemide and development of salt-sensitive hypertension in Dahl-S rats.
    Haugan K; Shalmi M; Petersen JS; Marcussen N; Spannow J; Christensen S
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1415-22. PubMed ID: 9067331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat.
    Randall MD; Douglas SA; Hiley CR
    Br J Pharmacol; 1989 Oct; 98(2):685-99. PubMed ID: 2684315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic neurohormonal modulation of mesenteric vascular tone.
    Hamza SM; Kaufman S
    Exp Physiol; 2012 Sep; 97(9):1054-64. PubMed ID: 22198012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.